Hepatocellular carcinoma tumour thrombus in a re-canalised para-umbilical vein: Detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging

British Journal of Radiology

Volumn 78, Issue 933, 2005, Pages 841-844

  Beadsmore, C J ^a   Cheow, H K ^a   Sala, E ^a   Lomas, D J ^a   Gibbs, P ^a   Save, V ^a   Alison, M E D ^a   Balan, K K ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; BIOPSY TECHNIQUE; CASE REPORT; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; RECANALIZATION; TUMOR THROMBUS; UMBILICAL VEIN;

CARCINOMA, HEPATOCELLULAR; CATHETERIZATION; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; UMBILICAL VEINS; VENOUS THROMBOSIS;

EID: 24344463523     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/37052159     Document Type: Article

References (16)

1. Parkin DM, Whelan SL, Ferlay J, et al, editors. Cancer incidence in five continents. Volume VII. Lyon, France: International Agency for Research on Cancer, 1997.
2. Di Bisceglie AM, Carithers RL Jr, Gores GJ. Hepatocellular carcinoma. Hepatology 1998;28:1161-5.
3. Chiaramonte M, Stroffolini T, Vian A, et al. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999;85:2132-7.
4. Nakashima T, Okuda K, Kojiro M, et al. Pathology of hepatocellular carcinoma in Japan. Cancer 1983;51: 863-77.
5. Chang JS, Chen SC, Chuang WL, Wang LY, Chang WY. Paraumbilical vein tumor thrombosis in hepatocellular carcinoma. Am J Gastrenterol 1994;89:1099-102.
6. Rigo P, Paulus P, Kaschten BJ, et al. Oncologic applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 1996;23:1641-74.
7. Warburg O. On the origin of cancer cells. Science 1956;123:309-14.
8. Valls C, Cos M, Figueras J, et al. Pretransplantaion diagnosis and staging of hepatocellular carcinoma in patients with cirrhosis: value of dual phase helical CT. AJR Am J Roentgenol 2004;182:1001-17.
9. Libbrecht L, Biden D, Verslype C, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002;8:749-61.
10. Wudel LJ, Delbeke D, Morris D, et al. The role of [18F] fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg 2003;69:117-24.
11. Jeng LB, Changlai SP, Shen YY, Lin CC, Tsai CH, Kao CH. Limited value of 18F-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Hepatogastroenterology 2003;50:2154-6.
12. Khan MA, Combs CS, Brunt EM, et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000;32:792-7.
13. Torizuka T, Tamaki N, Inokuma, et al. Value of fluorine-18-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 1994;35:1965-9.
14. Kikuchi M, Yamamoto E, Shiomi Y, et al. Internal and external jugular vein thrombosis with marked accumulation of FDG. Br J Radiol 2004;77:888-90.
15. Lin EC, Quaife RA. FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging. Clin Nucl Med 2001;26:241-2.
16. Miceli M, Atouli R, Walker R, et al. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol 2004;22:1949-56.